Latest National Cancer Institute News

Goldilocks treatment window could lead to cancer therapy without harmful side-effects
Bone loss medicines linked to lower ovarian cancer rates
Ludwig Princeton’s Eileen White named co-leader of $25 million Cancer Grand Challenges team tackling cancer cachexia
Schmitz receives $3.2 million to bring supportive cancer care to rural areas
New molecular subset of pediatric liver cancer identified
Smokers who switch to e-cigarettes may adopt other healthy routines
Simones career reboot: from IT to nursing
Ludwig MSK study modeling tumor evolution reveals vulnerability for cancer prevention and therapy
Fruit snack or edible? Study finds some cannabis products look like popular snacks
NCI-COG Pediatric MATCH study shows benefit of genetic screening in refractory tumors
Flavored tobacco sales restrictions impact availability, advertising
Study shows long-term safety of genetically modified immune effector cells
Lynparza reduced risk of death by 32% in adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer
Lynparza approved in US as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer
$2.5M grant awarded to flip switch on lung cancer drug resistance
WHO and St. Jude to dramatically increase global access to childhood cancer medicines
Common diabetes drug not effective against early-stage breast cancer, researchers say
Scientists studying new method to model bladder cancer treatments
New centre to harness data in classroom and empower learners for age of AI
Study looks at approaches for early diagnosis of pancreatic cancer
Gene signature IDs drivers of treatment resistance in metastatic breast cancer
Cancer costs U.S. more than $156 billion, with drugs leading expense
Baylor awarded NIH funding for Clinical Genome ResourceBaylor awarded NIH funding for Clinical Genome Resource
Micro-robots propelled by air bubbles and ultrasound
AI-powered microscope could check cancer margins in minutes
Unexpected discovery about stem cell immortality: study
A 20-second test to predict risk of major adverse events after surgery
Researchers join project to understand sex differences in brain cancer outcomes
Proteogenomics enhances identification of therapeutic vulnerabilities in breast cancer
Griffith and Nanostring launch Centre of Excellence in spatial biology
Baylor, VA to enhance breast cancer treatment for veterans
Dawn-to-sunset fasting could help those suffering from metabolic syndrome
Genetic risk factors identified for prostate cancer
Web resources bring new insight into COVID-19
UNSW academic awarded $1.5m grant for treatment of malignant melanoma
Novel PROTAC enhances its intracellular accumulation and protein knockdown
Baylor recruiting for study to observe COVID-19 in cancer patients
Tumour gene test could help to predict ovarian cancer prognosis
Ludwig Cancer Research study finds reprogramming of immune cells enhances effects of radiotherapy
Steep rise in skin cancer since 1960s
Typhoid’s relative may be key to curing disease
Ocean virus hijacks carbon-storing bacteria
Testing tuberculosis vaccine for COVID-19
Scientists double understanding of genetic risk of melanoma
Game theory suggests more efficient cancer therapy
Dawn-to-sunset fasting associated with anti-cancer proteins
Brain tumors trigger silencing of neuronal activity
Listening to your gut: A powerful new tool on microbiome and cell metabolism